GoHealth (NASDAQ:GOCO – Get Rating) had its price objective decreased by research analysts at Royal Bank of Canada from $15.00 to $14.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank of Canada’s price target suggests a potential upside of 5.90% from the stock’s current price.
Separately, Credit Suisse Group set a $7.00 target price on GoHealth in a report on Thursday, November 24th.
GoHealth Stock Performance
NASDAQ:GOCO opened at $13.22 on Friday. The stock has a market cap of $290.31 million, a PE ratio of -0.43 and a beta of 2.15. GoHealth has a fifty-two week low of $4.93 and a fifty-two week high of $25.50. The firm’s fifty day simple moving average is $15.86 and its 200-day simple moving average is $8.70. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 1.40.
Institutional Inflows and Outflows
GoHealth Company Profile
GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
- Get a free copy of the StockNews.com research report on GoHealth (GOCO)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.